Why are you reporting this TALK?
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
FDA approval of enfortumab/pembro for UC